Ascentage Pharma’s Olverembatinib Shows Promise in SDH-Deficient GIST at ESMO Congress
Ascentage Pharma (HKG: 6855), a biopharmaceutical company based in China, has announced the presentation of...
Company
Fosun Pharma to Acquire Full Stake in Fosun Kite Biotechnology for USD 27 Million
Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196, HKG: 2196) has disclosed plans to acquire...
Jiangsu Hengrui’s HER2-Targeted ADC SHR-A1811 Receives Priority Review from China’s NMPA
Jiangsu Hengrui Pharmaceuticals Co., Ltd (SHA: 600276), a leading pharmaceutical company in China, has announced...
Hangzhou-Based Ophthalmic Device Maker MDCO Secures RMB 200 Million in Series B Funding
MDCO, an ophthalmic medical device company headquartered in Hangzhou, has reportedly secured nearly RMB 200...
Beijing Wantai Biological and Fujian Provincial CDC Collaborate on Vaccine Development and Public Health Initiatives
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd (SHA: 603392), a leading biopharmaceutical company based in...
MGI Tech and Haihe Laboratory Deepen Collaboration with Introduction of CycloneSEQ-WT02
MGI Tech Co., Ltd, a prominent gene sequencing company based in China, has disclosed a...
MGI Tech and Sequanta Technologies Launch Advanced DCS Lab to Accelerate Omics Research
MGI Tech Co., Ltd, a leading gene sequencing specialist based in China, has entered into...
Moderna Inc. Announces Cost-Cutting Measures and Pipeline Realignment
Moderna Inc. (NASDAQ: MRNA), a leading mRNA technology company based in the U.S., has announced...
Sino Biological and BioGeometry Broaden Partnership to Advance AI-Driven Drug Discovery
Sino Biological (SHE: 301047), a leading biotech company in China, and BioGeometry have announced an...
Johnson & Johnson Submits Second NDA for Nipocalimab to Treat Generalized Myasthenia Gravis
Johnson & Johnson (NYSE: JNJ), a leading healthcare company based in the U.S., has reported...
Keymed Biosciences’ IL-4Rα mAb Stapokibart Receives NMPA Approval for Atopic Dermatitis Treatment
Keymed Biosciences Inc. (HKG: 2162), a biopharmaceutical company based in China, has announced that the...
South Korea’s MFDS Aims to Slash Drug Approval Times with New Innovation Plan
South Korea’s Ministry of Food and Drug Safety (MFDS) has unveiled an ambitious plan to...
Alibaba Health Forges Strategic Partnerships with Viatris and Chinese Pharma Companies for Digital Health Expansion
Alibaba Health Information Technology Ltd (HKG: 0241), the health industry arm of Chinese e-commerce giant...
Shanghai Bao Pharmaceutical and Subsidiary Secure Commercialization Rights Deal for SJ02 with Organon China
Shanghai Bao Pharmaceutical, a Chinese pharmaceutical company, along with its wholly-owned subsidiary Suzhou Centergene Pharmaceuticals,...
ChemPartner Pharmatech Enters Strategic Partnership with Malaysian Entities to Develop Innovative Drugs
ChemPartner Pharmatech Co., Ltd (SHE: 300149), a leading pharmaceutical company based in China, has joined...
Nona Biosciences and Umoja Biopharma Join Forces to Develop In Vivo CAR-T Therapies
Nona Biosciences, a subsidiary of HBM Holdings Ltd (HKG: 2142), has entered into a strategic...
Beijing’s MoleculeMind Secures Series A Funding to Accelerate AI Protein Design Innovations
MoleculeMind, a Beijing-based AI protein design platform, has reportedly secured a Series A financing round,...
Autobio Diagnostics Partners with MBL to Advance Microbial Mass Spectrometry Technology
Autobio Diagnostics Co., Ltd (SHA: 603658), a prominent player in China’s in vitro diagnostic market,...
Yestar Healthcare’s 2024 Interim Report Reflects Impact of Volume-Based Procurement on Revenue
Yestar Healthcare Holdings Co., Ltd., a leading distributor and service provider for in vitro diagnostic...
Sanofi’s Dupixent Shows Promise in Phase III Trials for Rare Skin Disease and Chronic Hives
Sanofi (EPA: SAN; NASDAQ: SNY), a leading French pharmaceutical company, has announced positive results from...